Explore

TrendlineTrendline
Corient Private Wealth LP Increases Stake in Xcel Energy Inc.

Corient Private Wealth LP Increases Stake in Xcel Energy Inc.

Corient Private Wealth LP Increases Stake in Xcel Energy Inc.
TrendlineTrendline
Amundi Sells Significant Stake in Acadia Healthcare Company, Inc.

Amundi Sells Significant Stake in Acadia Healthcare Company, Inc.

Amundi Sells Significant Stake in Acadia Healthcare Company, Inc.
TrendlineTrendline
Barclays Maintains 'Hold' Rating for Columbia Banking System (COLB) Amidst Positive Insider Sentiment

Barclays Maintains 'Hold' Rating for Columbia Banking System (COLB) Amidst Positive Insider Sentiment

Barclays Maintains 'Hold' Rating for Columbia Banking System (COLB) Amidst Positive Insider Sentiment
Rapid ReadRapid Read
Humana Study Reveals Significant Reduction in Hospitalizations and Costs for Cancer Patients with Specialty Pharmacy Care

Humana Study Reveals Significant Reduction in Hospitalizations and Costs for Cancer Patients with Specialty Pharmacy Care

Humana Inc. has released findings from a study indicating that cancer patients enrolled in its Medicare Part D plans who utilized CenterWell Specialty Pharmacy services experienced an 11.7% reduction in hospitalizations. The research, conducted by Humana Pharmacy Analytics and Consulting, also showed a 2.7% decrease in emergency department visits and a 7.7% reduction in overall medical costs for these beneficiaries. The study focused on the impact of pharmacy-led care coordination services, which emphasize medication adherence and continuous patient support. These services were provided by Humana’s CenterWell Specialty Pharmacy Oncology Center of Excellence (COE) over a one-year period. The COE program offers specialized clinical care and mail-order delivery for patients managing complex cancer diagnoses and therapies, including those prescribed intravenous chemotherapy, oral targeted oncolytics, and immunotherapies. The results of this retrospective, observational analysis were consistent across various p...
TrendlineTrendline
Humana Expands Healthcare Services and Employment Opportunities Across U.S.

Humana Expands Healthcare Services and Employment Opportunities Across U.S.

Humana Expands Healthcare Services and Employment Opportunities Across U.S.
TrendlineTrendline
Corient Private Wealth LP Reduces Holdings in Public Storage by 5.5%

Corient Private Wealth LP Reduces Holdings in Public Storage by 5.5%

Corient Private Wealth LP Reduces Holdings in Public Storage by 5.5%
TrendlineTrendline
Corient Private Wealth LP Reduces Stake in EOG Resources, Inc.

Corient Private Wealth LP Reduces Stake in EOG Resources, Inc.

Corient Private Wealth LP Reduces Stake in EOG Resources, Inc.
TrendlineTrendline
Tidal Investments LLC Reduces Stake in Scholastic Corporation (SCHL)

Tidal Investments LLC Reduces Stake in Scholastic Corporation (SCHL)

Tidal Investments LLC Reduces Stake in Scholastic Corporation (SCHL)
TrendlineTrendline
Guggenheim Initiates Coverage on Moog Inc. with 'Neutral' Rating

Guggenheim Initiates Coverage on Moog Inc. with 'Neutral' Rating

Guggenheim Initiates Coverage on Moog Inc. with 'Neutral' Rating
TrendlineTrendline
Occidental Petroleum Receives Upgraded Price Target from UBS Group Amidst Shifting Market Sentiment

Occidental Petroleum Receives Upgraded Price Target from UBS Group Amidst Shifting Market Sentiment

Occidental Petroleum Receives Upgraded Price Target from UBS Group Amidst Shifting Market Sentiment
ReutersReuters
Wells Fargo trims S&P 500 index's year-end target to 7,700

Wells Fargo trims S&P 500 index's year-end target to 7,700

Sept 15 (Reuters) - Wells Fargo lowered its year-end target for the S&P 500 index to 7,700 from 7,950, as limited catalysts for further gains, and rising political and sector-specific risks cloud the market outlook.
TrendlineTrendline
Baird Financial Group Inc. Adjusts Holdings in Novo Nordisk A/S

Baird Financial Group Inc. Adjusts Holdings in Novo Nordisk A/S

Baird Financial Group Inc. Adjusts Holdings in Novo Nordisk A/S